Additionally, Editas Medicine management will participate in the following upcoming investor conference in May: To access the live webcast of Editas Medicine’s presentation, please visit the ...

Scientists at Oak Ridge National Laboratory and the University of Colorado Boulder used a gene-silencing tool and a large ...

Hyderabad: In a landmark moment for Indian agricultural science, ICAR–Indian Institute of Rice Research (IIRR) at ...

Rebecca Buckley, David Robinson II and Feng Zhang will be recognized Sunday in Wallace Wade Stadium. Their professional ...

Why CRISPR-Cas SDN-1 is relevant to the UPSC exam? What is the significance of topics such as Sixteenth Finance Commission, ...

The biotech has nominated MB-111, a drug it's developing as a treatment for elevated triglycerides, as its first clinical development candidate.

Glioblastoma may be driven by 3D DNA folding patterns, not just mutations, offering new paths for treatment. A new ...

Liquidia Technologies (LQDA) witnessed a jump in share price last session on above-average trading volume. The latest trend ...

From STAT’s Adam Feuerstein: The FDA informed Capricor Therapeutics that a meeting of outside experts will be convened to ...

Pikes Peak State College students are benefitting from a new $1.5 million grant. It’ll give them first-hand experience with ...

Developed at the Children's Hospital of Philadelphia (CHOP) and called Zynteglo, the medicine uses the patient's own stem cells to cure them.

Why did the central govt unlawfully release two genome edited rice varieties in India?